[Disorders of coagulation/fibrinolysis and bleeding tendency]

Area of Science:

• Hepatology
• Hematology
• Coagulation Science

Context:

• The liver is central to hemostasis, producing coagulation and fibrinolysis factors.
• The hepatic reticuloendothelial system clears activated factors and inhibitors.
• Liver cirrhosis disrupts these functions, impacting bleeding and clotting.
• Hematological changes in cirrhosis include thrombocytopenia and factor abnormalities.

Purpose:

• To elucidate the multifaceted hemostatic alterations in liver cirrhosis.
• To highlight the role of diminished factor production and clearance in cirrhotic coagulopathy.
• To underscore the complexity of bleeding tendencies in liver disease.

Summary:

• Liver cirrhosis significantly reduces the synthesis of both procoagulant and anticoagulant factors.
• Impaired clearance by the reticuloendothelial system exacerbates hemostatic dysregulation.
• Cirrhosis presents with thrombocytopenia, hypersplenism, and qualitative coagulation factor defects.
• These combined effects result in a complex bleeding diathesis in cirrhotic patients.

Impact:

• Understanding these mechanisms is crucial for managing bleeding risks in liver cirrhosis.
• This knowledge informs the development of targeted therapies for cirrhotic coagulopathy.
• Improved management strategies can enhance patient outcomes and reduce complications.